Tuberculosis (TB) is an airborne disease caused by
Mycobacterium tuberculosis (M. tuberculosis). M. tuberculosis and seven very closely related mycobacterial species together comprise what is known as the M. tuberculosis complex. 1 Most, but not all, of these species have been found to cause disease in humans and extensively drug-resistant. TB is the major causes of death from infectious diseases worldwide. According to WHO, tuberculosis mostly affects young adults, in their most productive years. However, all age groups are at risk. Over 95% of cases and deaths are in developing countries. 2, 3 Recently, in 2012 FDA approved drug, bedaquiline 4 is introduced as an anti-tuberculosis drug, specifi cally approved for the treatment in multi-drug-resistant tuberculosis.
Since last decades, an important progress in the fi eld of molecular biology together with the development of high-throughput drug screening methodologies has led to an ever-increasing demand for fi nding a new drug candidate. In these perspective multicomponent reactions (MCRs), because of their effi ciency, ease of automation along with their chemical diversity-generating power, subtraction of byproducts, have attracted much attention in the fi eld of academic as well as industrial research community. 5, 6 Within the class of MCRs, based on the irregular reactivity of isocyanides, and in particular the Ugi reaction, have been among the most widely used pathway. 7, 8 The combination of MCRs with transition-metal-catalysis gives access Folia Medica I 2018 I Vol. 60 I No. 4 to complex molecules in few steps as compared to traditional multistep processes. 9 Typically, Ugi four component reactions (U-4CR) provide access to carboxamide-like derivatives by a one pot condensation of aldehyde, amine, carboxylic acid and isocyanide. 10, 11 An analogous of chromane scaffolds were well studied compounds and known for their considerable biological awareness in last few decades i.e. anti-tuberculosis 12 , anti-viral 13 and many more. On the other side in the fi eld of medicinal chemistry many other heterocycles containing fluorinated motif were also known for their prominent impending against H37Rv. The pharmacological active chroman-2-carboxilic acid (key starting material of Nebivolol-an Anti-hypertensive drug) 14 was standing for their own position in medicinal area. We synthesized potent group of compounds using chroman-2-carboxilic acid to generate a carboxamide linkage using Ugi multicomponent reaction as an anti-tubercular scaffold.
MATERIALS AND METHODS

GENERAL
Chemicals and solvents were purchased from the Sigma-Aldrich Chemical Co., Merck chemical, Finar and Spectrochem Ltd. All the chemicals were used without further purifi cation. Thin-layer chromatography was accomplished on 0.2 mm precoated plates of silica gel G60 F254 (Merck). Visualization was made under UV light (254 and 365 nm) or with an iodine vapor. IR spectra were recorded on an IR Affi nity-1S spectrophotometer (Shimadzu). 1 H (400 MHz) and 13 C (101.1 MHz) NMR spectra were recorded on a Bruker AVANCE II spectrometer in CDCl 3 . Chemical shifts are expressed in δ ppm downfi eld from TMS as an internal standard. Mass spectra were determined using a direct inlet probe on a GCMS-QP 2010 mass spectrometer (Shimadzu). Solvents were evaporated using a rotary evaporator. Melting points were measured in open capillaries.
CHEMISTRY
General procedure for the synthesis of N-((tert-Butylcarbamoyl) (substitutedphenyl)methyl)-6-fl uoro-N-(3,4,5-trimethoxyphenyl)chroman-2-carboxamide
Methanol was added with 6-flourochroman-2-carboxilic acid (3.5 gm, 0.017 mole), 3,4,5-trimethoxyaniline (3.26 gm, 0.017 mole), various substituted aromatic aldehyde (0.017 mole) and tert-butyl isocyanide (1.51 gm, 0.018 mole) were taken and stirred it at room temperature for 12.0 hrs. Completion of the reaction was monitored by TLC using hexane: ethyl acetate as a mobile phase. After completion of the reaction, the reaction mixture was poured onto crushed ice water and stirred at RT for 12.0 hrs. The reaction mass was fi ltered, washed with cold water and dried using a vacuum dryer. Purifi cation of the fi nal product was carried out by silica gel column chromatography (60-120 mesh) using ethyl acetate and hexane as an eluents. Recrystallization of crude product was carried out using ethanol to afford an analytically pure product (Reaction Scheme 1).
All the compounds of the series 5a-o were synthesized according to the above cited method and structural confi rmation was done by spectral analysis and further supported by XRD techniques. 
N-((tert-Butylcarbamoyl)(4-chlorophenyl)methyl)-6-fl uoro-N-(3,4,5-trimethoxyphenyl) chroman-2-car-
N-((tert-Butylcarbamoyl)(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)methyl)-6-fluoro-3,4-dihydro-N-(3,4,5-trimethoxyphenyl)-2H-chromene-
IN SILICO STUDIES
In-silico studies were conducted by comparing the synthesized molecule with rifampicin which is the standard drug used against tyrosine phosphatase PtpB protein (PDB ID: 1YWF, 296 amino acid containing) of Mycobacterium tuberculosis. 15 Ligands were generated by the online portal of UNM Biocomputing-University of New Mexico (http:// pasilla.health.unm.edu/tomcat/biocomp/convert) and docking studies were performed by PatchDock software with clustering root mean square deviation (RMSD) value of 4.0. 16 Finally the predicted protein-ligand bindings were visualized with PyMOL software (https://pymol.org/). 17 
RESULTS AND DISCUSSION
CHEMISTRY
Synthetic Optimization
As mentioned earlier, it was a condensation between four components, i.e. 6-fl ourochromane-2-carboxilic acid (1), 3,4,5-Trimethoxyaniline (2), Various aromatic aldehydes (3a-o) and tert-butyl isocyanide (4), gives racemic products in analytically comparable yield (5a-o) (Reaction Scheme 1). The Reaction was adopted by using greener solvent and reaction condition, i.e. it was carried out at room temperature by stirring without any catalyst. The purifi cation of this new type of carboxamide compounds can be accomplished by column chromatography on silica (Mesh Size: 60-120; Hexane: Ethyl acetate as an eluent) to provide better yield (describe in experimental section). The fi rst approach has the benefi t that, besides removal of unreacted components and chemical impurities, single enantiomers can be isolated in a single step purifi cation process. A reaction mechanism similar to that suggested by Ugi 18 has been followed in the proposed work. Confi rmation of single isomer was carried out by an X-ray structure determination technique of compound 5a. ORTEP diagram of compound 5a exhibited in Figure 1 which can exactly identify spatial arrangements of atoms as well as chiral geometry (CCDC No. 1402956). Among the solvents tested, methanol was the only solvent in which the reaction led to the formation of the target compound in reasonably higher yields ( Table 1) .
X-RAY diffraction technique: For Confi rmation of Final Adducts
Single crystal X-ray analysis of a suitable quality Goodness of fi t 0.782 crystal of compound 5a was performed with a Rigaku SCX mini diffractometer using graphite monochromated Mo-Kα radiation. All the calculations were performed using the crystal structure crystallographic software package except for refi nement, which was performed using SHELXL-97. 19, 20 All the hydrogen atoms were located in difference Fourier maps, and their coordinates were refi ned with isotropic displacement parameters. Table 2 summarizes the crystallographic data for compound 5a.
ANTITUBERCULAR ASSAY 21 Anti-tubercular screening was carried out at the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institute of Health (NIH), Bethesda, USA.
MIC under Aerobic Conditions
The MIC, IC 50 and IC 90 of compound 5a-5o (Table  3) were determined by measuring bacterial growth after 5 day in the presence of test compounds. Dose response curves were generated using the LevenbergMarquardt algorithm and the concentrations that resulted in 50 % and 90 % inhibition of growth were determined (IC 50 and IC 90 respectively). Rifampicin (100 μM) was chosen as the standard drugs for the comparison of antitubercular activity. The drug was dissolved in DMSO and diluted and tested as described above. The bottles were incubated at 75-80°C for 3 days for solidifi cation and sterilization. 21 From the results of preliminary antimycobacterial screening of compounds 5a-5o (Table 3) , it has been observed that compounds 5d, 5i and 5j shows comparative higher minimum inhibition concentration than other synthesized compounds, may be due to the presence of donating infl uence at 3 and 4 positions of aromatic nucleus but IC 50 and IC 90 value for the same compounds show that it is required in a reasonably higher concentration. Other compounds give moderate inhibitory value, which might be possible due to the withdrawing as well as steric hindrance of the substituents.
DOCKING STUDY
To obtain molecular insight, all ligands were further subjected to molecular docking study to obtain molecular interaction and generate the supportive coordination between in silico and in vitro results. By taking the "tyrosine phosphatase PtpB, a member of protein tyrosine phosphatases (PTP) superfamily "as the protein target, molecular docking study was performed with the synthesized lead compounds. Ribbion diagram of PtpB protein represents 44 % helical (15 helices; 133 residues), 6 % beta sheet (5 strands; 18 residues) and a P loop. 23 5b >200 >200 >200 5c >200 >200 >200 5d 79 53 >100 5e >200 >200 >200 5f >200 >200 >200 5g >200 >200 >200 5h >200 >200 >200 5i >200 93 >200 5j >200 64 >100 5k >200 >200 >200 5l >100 >200 >100 5m >200 >200 >200 5n >100 >100 >200 5o >200 >200 >200 Finally, considering in vitro and in silico molecular docking results, among these newly synthesized molecules, 5d gave the be best result and was considered as the best inhibitor of tyrosine phosphatase PtpB and can be an effective anti-tubercular drug.
Rifampicin
CONCLUSIONS
A new series of chromane-2-carboxamide derivatives (5a-5o) were synthesized from 6-fl ourochroman-2-carboxilic acid via the Ugi reaction and characterized by spectral and elemental analyses. These new chemical entities were evaluated for their in vitro antituberculosis activities against different pathogenic strains. Among the tested compounds, compound 5d displayed considerable antimycobacterial activities against H37Rv as a MIC, IC 50 and IC 90 . A lead molecule 5d implements better scoring based on binding surface with reference to rifampicin. Entire study shows that the docking was rigid for compounds other than 5d. The utilization of the remaining synthesized molecules were enabled us to permit more binding towards amino acids.
